Combined magnetic resonance imaging and magnetic resonance spectroscopy imaging in the diagnosis of prostate cancer: a systematic review and meta-analysis.
about
The role of magnetic resonance imaging (MRI) in focal therapy for prostate cancer: recommendations from a consensus panelMetabolic Imaging in Prostate Cancer: Where We AreMultiparametric-MRI in diagnosis of prostate cancerIdentification of Gastric Cancer Biomarkers Using 1H Nuclear Magnetic Resonance SpectrometryThermoacoustic contrast of prostate cancer due to heating by very high frequency irradiation.A feasibility study of novel ultrasonic tissue characterization for prostate-cancer diagnosis: 2D spectrum analysis of in vivo data with histology as gold standard.Everyman's prostate phantom: kiwi-fruit substitute for human prostates at magnetic resonance imaging, diffusion-weighted imaging and magnetic resonance spectroscopy.Diffusion-weighted imaging with apparent diffusion coefficient mapping and spectroscopy in prostate cancerDetection of fully refocused polyamine spins in prostate cancer at 7 T.Prostate cancer metabolite quantification relative to water in 1H-MRSI in vivo at 3 Tesla.Update on prostate imagingDiffusion-weighted magnetic resonance imaging for tumour response assessment: why, when and how?Metabolomics: a novel approach to early and noninvasive prostate cancer detection.Focal therapy for prostate cancer: patient selection and evaluation.Predictive value of MRI in the localization, staging, volume estimation, assessment of aggressiveness, and guidance of radiotherapy and biopsies in prostate cancer.Imaging treated prostate cancer.Multiparametric MRI of prostate cancer: an update on state-of-the-art techniques and their performance in detecting and localizing prostate cancer.Innovations in diagnostic imaging of localized prostate cancer.The status of surgery in the management of high-risk prostate cancer.Role of MRI in the diagnosis and management of prostate cancer.Multiparametric MRI for prostate cancer detection: performance in patients with prostate-specific antigen values between 2.5 and 10 ng/mL.Routine pelvic MRI using phased-array coil for detection of extraprostatic tumour extension: accuracy and clinical significance.Electrical property sensing biopsy needle for prostate cancer detection.Histology core-specific evaluation of the European Society of Urogenital Radiology (ESUR) standardised scoring system of multiparametric magnetic resonance imaging (mpMRI) of the prostate.31P NMR of phospholipid metabolites in prostate cancer and benign prostatic hyperplasia.Automatic conformal prescription of very selective saturation bands for in vivo 1H-MRSI of the prostate.Inter-reader agreement of the ESUR score for prostate MRI using in-bore MRI-guided biopsies as the reference standard.Multiparametric MRI for prostate cancer localization in correlation to whole-mount histopathology.Impact of the integration of proton magnetic resonance imaging spectroscopy to PI-RADS 2 for prediction of high grade and high stage prostate cancer.Validating multiparametric MRI for diagnosis and monitoring of prostate cancer in patients for active surveillance.Transrectal ultrasound-guided biopsy for prostate cancer detection: Systematic and/or magnetic-resonance imaging-targeted.
P2860
Q27006744-F5270B05-798A-4F73-A81B-633E0DD08DADQ28074429-4C4169C7-887B-4F12-9E41-782FE9C88952Q28081873-C6AAB06D-8D12-4CD7-A722-D72A48ABE8E2Q28553966-9995C1ED-2424-427D-99EA-35A69E73E880Q30393331-89D780CC-06E7-45B8-8377-E269243C4274Q30480275-7CCA3AD5-0FD9-4E49-924C-C7030E0E9B30Q31153190-D10FF301-E888-447B-8091-5B80FC19C3DEQ33464875-CAB73976-7CD8-4024-95F5-1CBFD9EC6F6EQ33711402-F28CD774-E54C-4732-A104-6D4346DCC5D5Q33849173-847804AD-FAB6-4071-B710-4D5CC9943D79Q33908505-582396C6-AE41-455E-A82D-52C58987C29FQ34256394-6284BB88-4D04-4F7A-AF76-ACE09F6BB2BEQ37850315-7A9C2F55-89D1-4E1F-9861-1406DFDD353CQ37965637-C5F5190B-72EE-4D88-B7E3-8B7550E4ACCEQ37968978-F48FF4B4-F70C-4E6D-9A34-3B86144E17D4Q38100661-921F6F24-7762-489A-85EB-79398B28DCBFQ38100740-3E589D6D-F086-4B53-84E1-67990713F5DBQ38146913-DC84A580-BF12-4B2D-BF56-8C351660DED8Q38211115-60E7A209-33B0-493B-A401-F6244BCF1CE8Q38586444-67463D2A-1703-425D-A3F6-E219D5402157Q40206375-D4046D3F-4A94-4804-BEBA-CEE035F79454Q41063995-29BD6E3B-A8ED-4CCB-BE09-B866789DB155Q43891703-056A2510-8459-4CE8-9CE4-02443673A4C4Q44487866-91865F83-239B-4C23-A0FF-9248C2988FF5Q44673076-CC480E23-0ACA-4C37-B309-2A68146578B3Q45309733-1FBCC609-F146-4EEC-A040-1B7C7DABE7D7Q45826149-2F1510AE-66BA-4275-987C-460159FDFB42Q46012032-EEF6B2C1-1F2A-45BD-860F-7EE81A0185C9Q46051598-A59A6348-47A1-40FF-90DD-A0A43EB9300DQ48263594-D5F41126-A2C1-43CE-89DC-ED9D55EC5384Q49573604-802BA141-EF43-4045-A723-BC37C03274CF
P2860
Combined magnetic resonance imaging and magnetic resonance spectroscopy imaging in the diagnosis of prostate cancer: a systematic review and meta-analysis.
description
2008 nî lūn-bûn
@nan
2008 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Combined magnetic resonance im ...... atic review and meta-analysis.
@ast
Combined magnetic resonance im ...... atic review and meta-analysis.
@en
type
label
Combined magnetic resonance im ...... atic review and meta-analysis.
@ast
Combined magnetic resonance im ...... atic review and meta-analysis.
@en
prefLabel
Combined magnetic resonance im ...... atic review and meta-analysis.
@ast
Combined magnetic resonance im ...... atic review and meta-analysis.
@en
P2093
P2860
P1433
P1476
Combined magnetic resonance im ...... atic review and meta-analysis.
@en
P2093
Dominik Weishaupt
Johann Steurer
John Kurhanewicz
Lucas M Bachmann
Martin Umbehr
Thomas M Kessler
Tullio Sulser
P2860
P304
P356
10.1016/J.EURURO.2008.10.019
P407
P50
P577
2008-10-18T00:00:00Z